User profiles for "author:D Flink"

Dina M Flink

Regeneron
Verified email at regeneron.com
Cited by 347

A review of the oncology patient's challenges for utilizing fertility preservation services

DM Flink, J Sheeder, LA Kondapalli - Journal of adolescent and …, 2017 - liebertpub.com
Purpose: The American Society of Clinical Oncology issued practice guidelines in 2006 to
provide critical information about fertility impact to adolescents and young adults (AYA) at …

[HTML][HTML] Odronextamab (REGN1979), a human CD20 x CD3 bispecific antibody, induces durable, complete responses in patients with highly refractory B-cell non …

R Bannerji, JN Allan, JE Arnason, JR Brown, R Advani… - Blood, 2020 - Elsevier
BACKGROUND: Odronextamab (REGN1979) is a first-in-class, hinge-stabilized, fully human
IgG4-based CD3 x CD20 bispecific antibody (bsAb) that has demonstrated encouraging …

Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant …

…, C Lefkowits, J Sheeder, K Matsuo, D Flink - JAMA network …, 2020 - jamanetwork.com
Importance Current guidelines recommend a 28-day course of enoxaparin for
thromboprophylaxis after surgery for gynecologic cancer. The high cost of this medication …

Sexual and marital dysfunction in women with gynecologic cancer

SR Guntupalli, J Sheeder, Y Ioffe, A Tergas… - International Journal of …, 2017 - ijgc.bmj.com
Objective Sexual dysfunction can be a long-term issue for women with gynecologic cancer.
This study assesses the extent of sexual and marital dysfunction women face following …

[HTML][HTML] Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies

…, U Ihenacho, L Figueroa, E Silverstein, D Flink… - Gynecologic oncology …, 2019 - Elsevier
Objectives To evaluate interest in and patterns of use of non-prescription cannabis products
for symptom management amongst gynecologic cancer patients living in states with legal …

Priorities in fertility decisions for reproductive-aged cancer patients: fertility attitudes and cancer treatment study

DM Flink, LA Kondapalli… - Journal of adolescent …, 2017 - liebertpub.com
Purpose: The Fertility Attitudes and Cancer Treatment Study (FACTS) aims at better
understanding the reasons and priorities of young adult cancer patients making decisions …

[HTML][HTML] Baseline biomarkers of T-cell function correlate with clinical responses to odronextamab (REGN1979), and loss of CD20 target antigen expression identified …

J Brouwer-Visser, N Fiaschi, RP Deering, A Dhanik… - Blood, 2020 - Elsevier
BACKGROUND: Odronextamab (REGN1979) is a first-in-class, hinge-stabilized, fully human
CD20 x CD3 IgG4-based bispecific antibody that binds to CD20-expressing cells and CD3 …

Do patient characteristics decide if young adult cancer patients undergo fertility preservation?

DM Flink, J Sheeder, LA Kondapalli - Journal of adolescent and …, 2017 - liebertpub.com
Purpose: The Fertility Attitudes and Cancer Treatment Study (FACTS) is a two-phase
research initiative aimed to understand factors involved with decision making for future …

Radiation therapy is not an independent risk factor for decreased sexual function in women with gynecologic cancers

MR Moroney, D Flink, J Sheeder… - Reports of Practical …, 2018 - journals.viamedica.pl
Aim To evaluate the associations of external beam radiation therapy (EBRT) and
intracavitary brachytherapy (IB) with decreased sexual function. Background There's …

Implementing the comprehensive, continuous, integrated system of care model for individuals with co-occurring disorders: Preliminary findings from a residential …

ML Harrison, KA Moore, MS Young, D Flink… - Journal of Dual …, 2008 - Taylor & Francis
This study assessed the effectiveness of an evidence-based treatment model for homeless
individuals with co-occurring diagnosed mental health and substance use disorders. The …